ALKEM LABORATORIES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,366.25 INR | +0.29% |
|
+0.89% | +22.37% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 83.44B | 88.65B | 106B | 116B | 127B | |||||
Total Assets | 99.43B | 115B | 141B | 138B | 156B | |||||
Interest Expense | -466M | -399M | -309M | -809M | -804M | |||||
Income Tax Expense | 1.1B | 2.24B | 1.64B | 2.98B | 2.12B | |||||
CAPEX | -3.63B | -1.95B | -3.39B | -2.33B | -2.59B | |||||
EBT | 12.6B | 18.42B | 18.44B | 13.05B | 20.23B | |||||
EBITDA | - | - | - | - | - | |||||
D&A | 2.44B | 2.65B | 2.94B | 2.99B | 2.86B | |||||
Net Income | 11.27B | 15.85B | 16.46B | 9.84B | 17.96B | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Real Estate Operators And Lessors | ||||||||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 56.06B | 58.21B | 75.27B | 81.6B | 86.62B | |||||
Total Assets | 26.32B | 25.57B | 25.9B | 25.58B | 25.85B | |||||
CAPEX | - | - | - | - | - | |||||
United States (US) | 22B | 24.67B | 23.29B | 25.13B | 27.71B | |||||
Total Assets | 5.96B | 5.84B | 5.99B | 3.97B | 3.98B | |||||
Other International | 5.38B | 5.78B | 7.78B | 9.26B | 12.35B | |||||
Total Assets | 430M | 452M | 519M | 515M | 486M | |||||
International | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Equities
- ALKEM Stock
- Financials Alkem Laboratories Limited
- Business Segments